| Literature DB >> 35607653 |
Jianmin Song1, Senmao Xia2, Demetris Vrontis3, Arun Sukumar4, Bing Liao1, Qi Li5,6, Kun Tian7, Nengzhi Yao8.
Abstract
Literature notes that firms are keen to develop big data analytics capability (BDAC, e.g. big data analytics (BDA) management and technology capability) to improve their competitive performance (e.g. financial performance and growth performance). Unfortunately, the extant literature has limited understanding of the mechanisms by which firms' BDAC affects their competitive performance, especially in the context of small and medium-sized enterprises (SMEs). Using resource capability as the theoretical lens, this paper specifically examines how BDAC influences SMEs' competitive performance via the mediating role of business models (BMs). Also, this study explores the moderating effect of COVID-19 on the relationship between BDAC and BMs. Supported by Partial Least Squares-Structural Equation Modelling (PLS-SEM) and data from 242 SMEs in China, this study finds the mediating roles of infrastructure and value attributes of BMs in enhancing the relationship of BDAC on competitive performance. Furthermore, the improvement of financial performance comes from the matching of BDA management capability with infrastructure attributes of BMs, while the improvements in growth come from the matching of BDA management capability and BDA technology capability with value attributes of BMs. The result also confirms the positive moderating effects of COVID-19 on the relationship of BDA management capability and value attributes of BMs. This study enriches the integration of BDAC and BMs literature by showing that the match between BDAC and BMs is vital to achieve competitive performance, and it is helpful for managers to adopt an informed BDA strategy to promote widespread use of BDAs and BMs.Entities:
Keywords: Big data analytics capability; Business model; COVID-19; Competitive performance; Dual attributes
Year: 2022 PMID: 35607653 PMCID: PMC9117985 DOI: 10.1007/s10796-022-10287-0
Source DB: PubMed Journal: Inf Syst Front ISSN: 1387-3326 Impact factor: 5.261
Fig. 1Theoretical research model
Descriptive statistics of samples (N = 242)
| Indexes | Category | Frequency | Per (%) | Indexes | Category | Frequency | Per (%) |
|---|---|---|---|---|---|---|---|
| Firm size (Number of employees) | 1-50 | 49 | 20.2% | Firm property | State-owned business | 71 | 29.3% |
| 51-150 | 50 | 20.7% | Private enterprises | 120 | 49.6% | ||
| 151-250 | 27 | 11.2% | Joint ventures | 21 | 8.7% | ||
| 251-500 | 37 | 15.3% | WFOE | 20 | 8.3% | ||
| Above 500 | 79 | 32.6% | Others | 10 | 4.1% | ||
| Industry | Manufacturing | 70 | 28.9% | Firm Age | <1 years | 7 | 2.9% |
| Retailing | 24 | 9.9% | 1-4 years | 50 | 20.7% | ||
| Foodservice | 28 | 11.6% | 5-8 years | 46 | 19.0% | ||
| IT | 38 | 15.7% | >8 years | 139 | 57.4% | ||
| Others | 82 | 33.9% |
Results of reliability of measurement model (N = 242)
| Constructs | Items | SFL | SE | t-valuea,b | SMC | VIF | α | CR | AVE | |
|---|---|---|---|---|---|---|---|---|---|---|
| BDAT | BDAT01 | 0.883 | 0.017 | 51.421 | 0.780 | 3.014 | 0.932 | 0.949 | 0.936 | 0.787 |
| BDAT02 | 0.918 | 0.012 | 79.289 | 0.843 | 3.927 | |||||
| BDAT03 | 0.896 | 0.013 | 70.790 | 0.803 | 3.307 | |||||
| BDAT04 | 0.875 | 0.016 | 55.283 | 0.766 | 2.900 | |||||
| BDAT05 | 0.862 | 0.025 | 34.375 | 0.743 | 2.756 | |||||
| BDAM | BDAM01 | 0.773 | 0.031 | 25.032 | 0.598 | 1.837 | 0.899 | 0.922 | 0.900 | 0.664 |
| BDAM02 | 0.831 | 0.024 | 34.811 | 0.691 | 2.267 | |||||
| BDAM03 | 0.817 | 0.025 | 32.883 | 0.667 | 2.235 | |||||
| BDAM04 | 0.852 | 0.020 | 41.696 | 0.726 | 2.597 | |||||
| BDAM05 | 0.781 | 0.028 | 28.036 | 0.610 | 1.954 | |||||
| BDAM06 | 0.833 | 0.024 | 35.180 | 0.694 | 2.327 | |||||
| BMI | BMI01 | 0.798 | 0.033 | 24.703 | 0.637 | 2.001 | 0.892 | 0.917 | 0.913 | 0.648 |
| BMI02 | 0.851 | 0.020 | 42.933 | 0.724 | 2.600 | |||||
| BMI03 | 0.858 | 0.021 | 40.174 | 0.736 | 2.851 | |||||
| BMI04 | 0.827 | 0.021 | 38.450 | 0.684 | 2.098 | |||||
| BMI05 | 0.739 | 0.048 | 15.254 | 0.546 | 1.959 | |||||
| BMI06 | 0.749 | 0.039 | 19.352 | 0.561 | 1.970 | |||||
| BMV | BMV01 | 0.846 | 0.021 | 39.575 | 0.716 | 2.557 | 0.920 | 0.938 | 0.922 | 0.715 |
| BMV02 | 0.866 | 0.016 | 55.682 | 0.750 | 2.869 | |||||
| BMV03 | 0.882 | 0.015 | 57.837 | 0.778 | 3.708 | |||||
| BMV04 | 0.846 | 0.019 | 45.381 | 0.716 | 2.886 | |||||
| BMV05 | 0.858 | 0.023 | 37.837 | 0.736 | 2.765 | |||||
| BMV06 | 0.771 | 0.035 | 22.151 | 0.594 | 2.048 | |||||
| GP | GP01 | 0.877 | 0.029 | 30.504 | 0.769 | 2.694 | 0.871 | 0.919 | 0.904 | 0.792 |
| GP02 | 0.904 | 0.017 | 52.980 | 0.817 | 2.604 | |||||
| GP03 | 0.888 | 0.018 | 48.904 | 0.789 | 1.978 | |||||
| FP | FP01 | 0.898 | 0.016 | 57.361 | 0.806 | 2.159 | 0.865 | 0.917 | 0.877 | 0.787 |
| FP02 | 0.871 | 0.020 | 42.684 | 0.759 | 2.225 | |||||
| FP03 | 0.893 | 0.015 | 59.961 | 0.797 | 2.355 | |||||
| COVID-19 | COV01 | 0.823 | 0.026 | 31.822 | 0.677 | 2.340 | 0.915 | 0.934 | 0.916 | 0.702 |
| COV02 | 0.866 | 0.018 | 47.959 | 0.750 | 2.927 | |||||
| COV03 | 0.871 | 0.016 | 54.988 | 0.759 | 3.040 | |||||
| COV04 | 0.838 | 0.017 | 49.005 | 0.702 | 2.497 | |||||
| COV05 | 0.786 | 0.026 | 30.721 | 0.618 | 1.942 | |||||
| COV06 | 0.840 | 0.020 | 41.722 | 0.706 | 2.562 |
SFL = Standardized factor loading; SE = Standard error; α = Cronbach’s Alpha; C.R = Composite reliability;
AVE = Average variance extracted; SMC = Square Multiple Correlations; Dijstra-Henseler’s rho;
a = Test-statistics are obtained by 5000 Bootstrapping runs;
b = Absolute t-values >1.96 are two-tailed significant at 5% level;
BDAT = BDA technology capability; BDAM = BDA management capability; BMI = infrastructure attribute of BMs; BMV = value attribute of BMs; GP = growth performance; FP = financial performance; COVID-19 = COVID-19.
Results of convergence and discriminate validity (N = 242)
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
|---|---|---|---|---|---|---|---|
| 1. BDAT | 0.506 | 0.094 | 0.670 | 0.202 | 0.115 | 0.469 | |
| 2. BDAM | 0.466** | 0.168 | 0.713 | 0.441 | 0.202 | 0.467 | |
| 3. BMI | −0.066 | 0.142 | 0.125 | 0.110 | 0.396 | 0.078 | |
| 4. BMV | 0.624** | 0.649** | 0.096 | 0.360 | 0.121 | 0.570 | |
| 5. GP | 0.187** | 0.406** | −0.095 | 0.338** | 0.059 | 0.304 | |
| 6. FP | 0.100 | 0.176** | 0.368** | 0.107 | −0.043 | 0.070 | |
| 7.COVID-19 | 0.437 | 0.424** | 0.061 | 0.524** | 0.274** | 0.031 |
significance level: p<0.05*; p<0.01**; p<0.001***;
Diagonal elements are the square roots of the AVE;
The elements appearing in the lower-left are the Pearson correlation coefficient between constructs;
The elements appearing in the upper-right are the HTMT values;
BDAT = BDA technology capability; BDAM = BDA management capability; BMI = infrastructure attribute of BMs; BMV = value attribute of BMs; GP = growth performance; FP = financial performance; COVID-19 = COVID-19.
Results of path analysis (N = 242)
| Structural path Hypothesized links (direct effect) | Path coefficients | Supported or not? | 95% BCa confidence interval | Effects size ( |
|---|---|---|---|---|
| BDAT → BMI | −0.169* | Not supported | [−0.308, −0.026] | 0.023 |
| BDAT→ BMV | 0.411*** | Supported | [0.266, 0.553] | 0.296 |
| BDAM→ BMI | 0.223** | Supported | [0.064, 0.373] | 0.041 |
| BDAM→ BMV | 0.458*** | Supported | [0.311, 0.599] | 0.367 |
| BMI → FP | 0.361*** | Supported | [0.255, 0.470] | 0.151 |
| BMI → GP | −0.128* | Not supported | [−0.237, −0.016] | 0.019 |
| BMV → FP | 0.072 | Not supported | [−0.037, 0.185] | 0.006 |
| BMV → GP | 0.351*** | Supported | [0.251, 0.465] | 0.141 |
significance level: p<0.05*; p<0.01**; p<0.001***; BCa = Bias-corrected and accelerated;
R2 = Determination coefficients; Q2 = Predictive relevance of endogeneity (omission distance = 7);
BDAT = BDA technology capability; BDAM = BDA management capability; BMI = infrastructure attribute of BMs; BMV = value attribute of BMs; GP = growth performance; FP = financial performance.
Fig. 2Path relationship model. Note: significance level: p<0.05*; p<0.01**; p<0.001***
Mediation analysis results (N = 242)
| Direct effect on GP | Direct effect on FP | Indirect effects on GP | Indirect effects on FP | |||
|---|---|---|---|---|---|---|
| Through BMI | Through BMV | Through BMI | Through BMV | |||
| BDAT | 0.166*** | −0.031 | 0.022 [0.000, 0.052] | 0.144*** [0.095, 0.205] | −0.061* [−0.121, −0.008] | 0.030 [−0.016, 0.079] |
| BDAM | 0.132** | 0.114** | −0.029 [−0.060, −0.002] | 0.161*** [0.090, 0.257] | 0.081* [0.022, 0.151] | 0.033 [−0.016, 0.092] |
significance level: p<0.05*; p<0.01**; p<0.001***;
[] is 95% BCa confidence interval; bootstrapping set is 5000;
BDAT = BDA technology capability; BDAM = BDA management capability; BMI = infrastructure attribute of BMs; BMV = value attribute of BMs; GP = growth performance; FP = financial performance
Results of hierarchical regression (N = 242)
| BMI | BMV | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | Model 6 | Model 7 | Model 8 | Model 9 | Model 10 | |
| −0.029 | −0.021 | −0.017 | −0.019 | −0.018 | −0.018 | 0.028 | 0.058 | 0.032 | 0.053 | |
| −0.011 | −0.004 | −0.021 | −0.003 | −0.020 | 0.089 | 0.013 | 0.032 | 0.015 | 0.033 | |
| 0.113 | 0.111 | 0.127 | 0.109 | 0.130 | −0.147 | −0.110* | −0.082 | −0.114* | −0.066 | |
| −0.024 | −0.008 | −0.012 | −0.007 | −0.011 | −0.019 | −0.031 | 0.045 | −0.030 | 0.050 | |
| BDAT | −0.125 | −0.126 | 0.489*** | 0.487*** | ||||||
| BDAM | 0.142* | 0.149* | 0.514*** | 0.551*** | ||||||
| COVID-19 | 0.110 | 0.064 | 0.107 | 0.001 | 0.302*** | 0.307*** | 0.297*** | 0.319*** | ||
| BDAT ×COVID-19 | −0.029 | −0.045 | ||||||||
| BDAM×COVID-19 | 0.021 | 0.109* | ||||||||
| 0.011 | 0.027 | 0.030 | 0.027 | 0.031 | 0.036 | 0.484 | 0.505 | 0.486 | 0.515 | |
| Adj- | −0.005 | 0.002 | 0.006 | −0.002 | 0.002 | 0.019 | 0.471 | 0.492 | 0.470 | 0.500 |
| ∆ | 0.016 | 0.019 | 0.016 | 0.020 | 0.448 | 0.469 | 0.450 | 0.479 | ||
| 0.671 | 1.073 | 1.226 | 0.944 | 1.059 | 2.197 | 36.705*** | 39.970*** | 31.575*** | 35.491*** | |
significance level: p<0.05*; p<0.01**; p<0.001***; BDAT = BDA technology capability; BDAM = BDA management capability; BMI = infrastructure attribute of BMs; BMV = value attribute of BMs; GP = growth performance; FP = financial performance; COVID-19 = COVID-19
Fig. 3Moderating effect of COVID-19. Note: BDAM = BDA management capability; BMV = value attribute of BMs; COVID-19 = COVID-19
| BDA technology capability | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | ||
| -Software applications of our organization can be easily used across multiple analytics platforms. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | ||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | ||
| BDA management capability | —We continuously examine innovative opportunities for the strategic use of business analytics. | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| —We perform business analytics planning processes in systematic ways. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| —When we make business analytics investment decisions, we estimate the effect they will have on the productivity of the employees’ work. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| —When we make business analytics investment decisions, we project how much these options will help end users make quicker decisions. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| —In our organization, information is widely shared between business analysts and line people so that those who make decisions or perform jobs have access to all available know-how. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| —In our organization, the responsibility for analytics development is clear. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| Infrastructure attribute | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | ||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | ||
| -Our organization’s business model builds a variety of distribution channels. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| -Our organization set up a special organization to keep in touch with customers. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| -Our organization has built a perfect partner network. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| Value attribute | -Our organization reduces inventory, marketing, sales and other costs through the business model. | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| -Through the business model, our organization reduces mistakes in the process of business transactions. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| -Our organization’s business model creates new ways to make money. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| -Our organization’s business model creates new profit points. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| -Our organization provides customers with novel value experience through business model. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| -Our organization has a unique mode of operation, creating novel products/services. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| Growth performance | -The sales growth of our organization is relatively satisfactory. | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| -The market share growth rate of our organization is relatively satisfactory. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| -The growth rate of new employees is still satisfactory. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| Financial performance | -The market share of our organization is still relatively satisfactory. | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| -The rate of return on investment of our organization is still satisfactory. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| -The profit level of our organization is still satisfactory. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| —The COVID-19 epidemic has had an adverse impact on our organization. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| —The COVID-19 has made daily work even more challenging. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| —The COVID-19 epidemic has added to concerns about their future development. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| —The COVID-19 epidemic has inspired our organization to take the initiative to expand business. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| —The COVID-19 epidemic has caused me to work longer hours. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| —The COVID-19 epidemic has made work more demanding. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |